Zent2U - Zentiva B2B Platform

Zent2U - Zentiva B2B Platform
Product Description

Zent2U (www.zent2u.com) is a B2B platform of Zentiva established in 2019 to collaborate with customers on:

- Licensing-out dossiers developed by Zentiva

- Co-development opportunities by co-financing Zentiva's products in development

- CMO services by Zentiva in production sites network in Czech Republic, Romania and India

- selling APIs developed and manufactured by Zentiva


Zentiva

  • CZ
  • 2019
    On CPHI since
Specifications
  • Supplied from
    Czech Republic; India; Romania

Zentiva

  • CZ
  • 2019
    On CPHI since

More Products from Zentiva (3)

  • Value Added Dasatinib

    Product Value Added Dasatinib

    Value added Dasatinib (Teaser attached)  •  Dasatinib is a targeted therapy used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL)  •  Current available products on the market are not completely absorbed by those patients ...
  • Value Added Abiraterone

    Product Value Added Abiraterone

    Value added Abiraterone  •  Abiraterone is a medication used to treat prostate cancer  •  The recommended dose is 1,000 mg as a single daily dose that must not be taken with food.  •  Administering  with food results up to a 10-fold (AUC) and up to a 17-fo...
  • Innovative combination Finasteride + Tadalafil

    Product Innovative combination Finasteride + Tadalafil

    Innovative combination Finasteride + Tadalafil   • Both products individually are approved for BPH (Benign prostatic hyperplasia) in Europe.  • The most frequent adverse reactions are impotence and decreased libido in Finasteride. The benefit of Tadalafil is early onset of the...

Zentiva resources (2)